Shailendra K. Gupta

Dr. Shailendra K. Gupta

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2013 in ACS Nano
Verified
Journal Article
Closed access
STShashi Kant Tiwari
Shashi Kant Tiwari
SASwati Agarwal
Swati Agarwal
BSBrashket Seth
Brashket Seth
AYAnuradha Yadav
Anuradha Yadav
SNSaumya Nair
Saumya Nair
KGKailash Chand Gupta
Kailash Chand Gupta

28 June 2012 in Environmental Health
Verified
Journal Article
Open access
PDF file
SSSuchi Smita
Suchi Smita
SGShailendra K. Gupta
Shailendra K. Gupta
ABAlena Bartonova
Alena Bartonova
Maria DusinskaMaria Dusinska
Maria Dusinska
AGArno Christian Gutleb
Arno Christian Gutleb
QRQamar Rahman
Qamar Rahman
Nanoparticles (NPs) cause concern for health and safety as their impact on the environment and humans is not known. Relatively few studies have investigated the toxicological and environmental effects of exposure to naturally occurring NPs (NNPs) and man-made or engineered NPs (ENPs) that are known to have a wide variety of effects once taken up into an organism. A review of recent knowledge (between 2000-2010) on NP sources, and their behaviour, exposure and effects on the environment and humans was performed. An integrated approach was used to comprise available scientific information within an interdisciplinary logical framework, to identify knowledge gaps and to describe environment and health linkages for NNPs and ENPs. The causal diagram has been developed as a method to handle the complexity of issues on NP safety, from their exposure to the effects on the environment and health. It gives an overview of available scientific information starting with common sources of NPs and their interactions with various environmental processes that may pose threats to both human health and the environment. Effects of NNPs on dust cloud formation and decrease in sunlight intensity were found to be important environmental changes with direct and indirect implication in various human health problems. NNPs and ENPs exposure and their accumulation in biological matrices such as microbiota, plants and humans may result in various adverse effects. The impact of some NPs on human health by ROS generation was found to be one of the major causes to develop various diseases. A proposed cause-effects diagram for NPs is designed considering both NNPs and ENPs. It represents a valuable information package and user-friendly tool for various stakeholders including students, researchers and policy makers, to better understand and communicate on issues related to NPs.

4 August 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
FKFaiz M. Khan
Faiz M. Khan
SMStephan Marquardt
Stephan Marquardt
SGShailendra K. Gupta
Shailendra K. Gupta
SKSusanne Knoll
Susanne Knoll
USUlf Schmitz
Ulf Schmitz
BPBrigitte M. Pützer
Brigitte M. Pützer
Cancer is a disease of subverted regulatory pathways. In this paper, we reconstruct the regulatory network around E2F, a family of transcription factors whose deregulation has been associated to cancer progression, chemoresistance, invasiveness, and metastasis. We integrate gene expression profiles of cancer cell lines from two E2F1-driven highly aggressive bladder and breast tumors, and use network analysis methods to identify the tumor type-specific core of the network. By combining logic-based network modeling, in vitro experimentation, and gene expression profiles from patient cohorts displaying tumor aggressiveness, we identify and experimentally validate distinctive, tumor type-specific signatures of receptor proteins associated to epithelial–mesenchymal transition in bladder and breast cancer. Our integrative network-based methodology, exemplified in the case of E2F1-induced aggressive tumors, has the potential to support the design of cohort- as well as tumor type-specific treatments and ultimately, to fight metastasis and therapy resistance.

1 November 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
STShashi Kant Tiwari
Shashi Kant Tiwari
BSBrashket Seth
Brashket Seth
SASwati Agarwal
Swati Agarwal
AYAnuradha Yadav
Anuradha Yadav
MKMadhumita Karmakar
Madhumita Karmakar
RCRajnish Kumar Chaturvedi
Rajnish Kumar Chaturvedi
Neurogenesis involves generation of new neurons through finely tuned multistep processes, such as neural stem cell (NSC) proliferation, migration, differentiation, and integration into existing neuronal circuitry in the dentate gyrus of the hippocampus and subventricular zone. Adult hippocampal neurogenesis is involved in cognitive functions and altered in various neurodegenerative disorders, including Alzheimer disease (AD). Ethosuximide (ETH), an anticonvulsant drug is used for the treatment of epileptic seizures. However, the effects of ETH on adult hippocampal neurogenesis and the underlying cellular and molecular mechanism(s) are yet unexplored. Herein, we studied the effects of ETH on rat multipotent NSC proliferation and neuronal differentiation and adult hippocampal neurogenesis in an amyloid β (Aβ) toxin-induced rat model of AD-like phenotypes. ETH potently induced NSC proliferation and neuronal differentiation in the hippocampus-derived NSC in vitro. ETH enhanced NSC proliferation and neuronal differentiation and reduced Aβ toxin-mediated toxicity and neurodegeneration, leading to behavioral recovery in the rat AD model. ETH inhibited Aβ-mediated suppression of neurogenic and Akt/Wnt/β-catenin pathway gene expression in the hippocampus. ETH activated the PI3K·Akt and Wnt·β-catenin transduction pathways that are known to be involved in the regulation of neurogenesis. Inhibition of the PI3K·Akt and Wnt·β-catenin pathways effectively blocked the mitogenic and neurogenic effects of ETH. In silico molecular target prediction docking studies suggest that ETH interacts with Akt, Dkk-1, and GSK-3β. Our findings suggest that ETH stimulates NSC proliferation and differentiation in vitro and adult hippocampal neurogenesis via the PI3K·Akt and Wnt·β-catenin signaling.

26 August 2016 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
MJMahdi Jalili
Mahdi Jalili
Ali Salehzadeh-YazdiAli Salehzadeh-Yazdi
Ali Salehzadeh-Yazdi
SGShailendra K. Gupta
Shailendra K. Gupta
OWOlaf Wolkenhauer
Olaf Wolkenhauer
MYMarjan Yaghmaie
Marjan Yaghmaie
KAKamran Alimoghaddam
Kamran Alimoghaddam
Evolution of Centrality Measurements for the Detection of Essential Proteins in Biological Networks

1 October 2021 in Molecular Systems Biology
Verified
Journal Article
Open access
MOMarek Ostaszewski
Marek Ostaszewski
Anna NiarakisAnna Niarakis
Anna Niarakis
AMAlexander Mazein
Alexander Mazein
IKInna Kuperstein
Inna Kuperstein
RPRobert Phair
Robert Phair
RSReinhard Schneider
Reinhard Schneider
We need to effectively combine the knowledge from surging literature with complex datasets to propose mechanistic models of SARS‐CoV‐2 infection, improving data interpretation and predicting key targets of intervention. Here, we describe a large‐scale community effort to build an open access, interoperable and computable repository of COVID‐19 molecular mechanisms. The COVID‐19 Disease Map (C19DMap) is a graphical, interactive representation of disease‐relevant molecular mechanisms linking many knowledge sources. Notably, it is a computational resource for graph‐based analyses and disease modelling. To this end, we established a framework of tools, platforms and guidelines necessary for a multifaceted community of biocurators, domain experts, bioinformaticians and computational biologists. The diagrams of the C19DMap, curated from the literature, are integrated with relevant interaction and text mining databases. We demonstrate the application of network analysis and modelling approaches by concrete examples to highlight new testable hypotheses. This framework helps to find signatures of SARS‐CoV‐2 predisposition, treatment response or prioritisation of drug candidates. Such an approach may help deal with new waves of COVID‐19 or similar pandemics in the long‐term perspective.